Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1971 Nov 30;134(6):1591–1600. doi: 10.1084/jem.134.6.1591

A BLOOD COAGULATION ABNORMALITY IN RABBITS DEFICIENT IN THE SIXTH COMPONENT OF COMPLEMENT (C6) AND ITS CORRECTION BY PURIFIED C6

Theodore S Zimmerman 1, Carlos M Arroyave 1, Hans J Müller-Eberhard 1
PMCID: PMC2139107  PMID: 5126641

Abstract

Evidence for the involvement of the sixth component of complement (C6) in normal blood coagulation is provided by the description of a coagulation abnormality in rabbits with a genetic C6 deficiency and by its correction with highly purified preparations of C6. Whole blood clotting time in glass or plastic was prolonged and prothrombin consumption was decreased in blood from the deficient animals. Other parameters of blood coagulation were normal, including prothrombin time, partial thromboplastin time, specific clotting factor activities, platelet factor III function, platelet count, and bleeding time. Clotting time and prothrombin consumption became normal when physiologic amounts of highly purified C6 were added to the deficient blood. Partial consumption of C6 hemolytic activity, with a time course similar to the consumption of prothrombin, was demonstrated during the clotting of normal human blood.

Full Text

The Full Text of this article is available as a PDF (487.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowie E. J., Thompson J. H., Jr, Owen C. A., Jr Standardization of platelets in the thromboplastin generation test. Am J Clin Pathol. 1965 Dec;44(6):673–677. doi: 10.1093/ajcp/44.6.673. [DOI] [PubMed] [Google Scholar]
  2. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  3. DUCKERT F., FLUCKIGER P., ISENSCHMID H., MATTER M., VOGEL-MENG J., KOLLER F. A modification of the thromboplastin generation test. Acta Haematol. 1954 Sep;12(3):197–202. doi: 10.1159/000204619. [DOI] [PubMed] [Google Scholar]
  4. HJORT P., RAPAPORT S. I., OWREN P. A. A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension. J Lab Clin Med. 1955 Jul;46(1):89–97. [PubMed] [Google Scholar]
  5. JACKSON D. P., HARTMANN R. C., CONLEY C. L. Clot retraction as a measure of platelet function. II. Clinical disorders associated with qualitative platelet defects (thrombocytopathic purpura). Bull Johns Hopkins Hosp. 1953 Dec;93(6):370–385. [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. MUSTARD J. F., HEGARDT B., ROWSELL H. C., MACMILLAN R. L. EFFECT OF ADENOSINE NUCLEOTIDES ON PLATELET AGGREGATION AND CLOTTING TIME. J Lab Clin Med. 1964 Oct;64:548–559. [PubMed] [Google Scholar]
  8. Nelson R. A., Jr, Biro C. E. Complement components of a haemolytically deficient strain of rabbits. Immunology. 1968 Apr;14(4):527–540. [PMC free article] [PubMed] [Google Scholar]
  9. RATNOFF O. D. An accelerating property of plasma for the coagulation of fibrinogen by thrombin. J Clin Invest. 1954 Aug;33(8):1175–1182. doi: 10.1172/JCI102990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. RATNOFF O. D., DAVIE E. W. The purification of activated Hageman factor (activated factor XII). Biochemistry. 1962 Nov;1:967–975. doi: 10.1021/bi00912a005. [DOI] [PubMed] [Google Scholar]
  11. ROBBINS J., STETSON C. A., Jr An effect of antigen-antibody interaction on blood coagulation. J Exp Med. 1959 Jan 1;109(1):1–8. doi: 10.1084/jem.109.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rother K., Rother U., Müller-Eberhard H. J., Nilsson J. R. Deficiency of the sixth component of complement in rabbits with an inherited complement defect. J Exp Med. 1966 Oct 1;124(4):773–785. doi: 10.1084/jem.124.4.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SPAET T. H., CINTRON J. STUDIES ON PLATELET FACTOR-3 AVAILABILITY. Br J Haematol. 1965 May;11:269–275. doi: 10.1111/j.1365-2141.1965.tb06587.x. [DOI] [PubMed] [Google Scholar]
  14. STORMORKEN H. The preparation of proaccelerin deficient (parahemophilia) plasma for the assay of proaccelerin. Scand J Clin Lab Invest. 1957;9(3):273–276. doi: 10.3109/00365515709079970. [DOI] [PubMed] [Google Scholar]
  15. Taylor F. B., Müller-Eberhard H. J. Factors influencing lysis of whole blood clots. Nature. 1967 Dec 9;216(5119):1023–1025. doi: 10.1038/2161023a0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES